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Abstract 
Objectives: The purpose of this paper is to determine the culturally based values, attitudes and 
beliefs that influence African American men in their decisions to undergo prostate cancer 
screening. These beliefs, values and concerns will then be used to create a research design to 
assess effectiveness of a culturally tailored intervention (educational video and values 
clarification exercise) in helping men make decisions that are consistent with their values and 
beliefs, by increasing knowledge, identifying values, attitudes and beliefs, reducing decisional 
conflict and identifying preferred role in decision making. 
Methods: A systematic evidence review was conducted to determine the culturally specific 
values, attitudes and beliefs of African American, Latino and White men. The thematic results of 
the systematic evidence review were used to craft a research design including surveys, 
educational videos, and values clarification exercises (social matching and ranking and rating). 
Results: Important recurring themes were identified in the systematic evidence review. These 
themes included lack of knowledge, machismo, fear, patient doctor relationship, family and faith. 
All men reported poor patient doctor relationship, negative perceptions of prostate cancer, lack 
of knowledge and the importance of family. African American and Latino men were more likely 
to fear prostate cancer screening methods (DRE). All groups gave specific and unique 
suggestions for the content, design and themes they would prefer in educational materials. 
In the research design, the primary outcomes will be knowledge, decisional conflict and 
values, attitudes and beliefs and preferred role in decision making. We do not expect a 
statistically significant difference between groups in intent to screen and knowledge. However, a 
statistically significant difference in decisional conflict is hypothesized between the culturally 
tailored, neutral and no education groups. Values, attitudes and beliefs will be assessed through 
values clarification exercises and survey questions. We expect that importance of support 
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Introduction 
Prostate cancer is the most common cause of non-melanoma cancer in men as well as 
the second leading cause of cancer related mortality in American men (tl. Age is perhaps the 
most important risk factor since prostate cancer is rarely diagnosed before the age of 45 (2). 
Diets high in animal fat and alcohol and low in fruits and vegetables have been associated with 
higher prostate cancer risk (3·4·5). Race and family history are also important risk factors in 
prostate cancer. African Americans are disproportionately affected by high prostate cancer 
incidence, morbidity and mortality (tl. The incidence rates of prostate cancer in the overall 
population and African Americans peaked in 19931argely due to the advancements made in 
screening and diagnostic measures (tl. Since 1993, the number of prostate cancer cases and 
deaths has steadily declined due to better treatment efficacy, however the large disparity in 
cases and mortality between African Americans and the rest of the population remain. 
Therefore, culturally tailored interventions are of particular interest in prostate cancer prevention 
in this population. 
For all populations, prostate cancer screening is currently an area of intense debate. 
Awareness surrounding the prevalence of prostate cancer has raised media coverage and 
increased screening rates. However, the media reports are not educating men on the 
uncertainties surrounding the benefits of screening (77). Treatment side effects may permanently 
and unnecessarily impact patient quality of life. Men should be aware of these issues and be 
empowered to make their own personal decision regarding screening. Professional 
organizations recommend that physicians fill the role of educator and invite men to participate in 
the decision making process. 
In this paper, current prostate cancer prevention strategies and recommendations will be 
discussed. New strategies that involve patient participation in prostate cancer prevention, such 
as culturally based values clarification and decision aids, will be presented. I will also discuss 
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agents that will decrease their risk of developing cancer without conferring unnecessary harm 
on the individual. Multiple agents have been studied, including anti-androgens, non-steroidal 
anti-inflammatory drugs (NSAIDS), Caretenoids, Selenium and Vitamins C, D and E. To date, 
studies have shown conflicting findings on the efficacy of vitamin and mineral supplementation 
in the primary prevention of prostate cancer. 
Anti-Androgen Therapy 
The primary prevention of prostate cancer with anti-androgens, such as 5-alpha 
reductase inhibitors, is of particular interest in African American men given reports of higher 
androgen levels and the known androgen dependent nature of prostate cancer ('l. The use of 
the anti-androgen, Finasteride, has shown promise in the Prostate Cancer Prevention Trial 
(PCPT) (B3) 
The study enrolled 24,482 men and randomized 18,882 men who were::: 55 years old, with 
normal digital rectal exam (ORE), PSA levels <3.0ng/ml and no clinically significant coexisting 
conditions. Healthy men were randomized to Finasteride therapy (n = 9,423) or placebo (n = 
9457) over a seven year period. Baseline characteristics were similar between groups, selection 
bias was minimal with similar loss to follow up rates in both the intervention and placebo groups 
(8% vs. 7.4%). Researchers utilized an intention to treat analysis for loss to follow up, 
crossovers and drop-ins. 
To assess adherence, study participants were included in a 3 month placebo run-in 
period after which they were randomized by an unspecified dynamic allocation scheme to 
ensure balanced randomization throughout the 221 study sites. Annually, participants received 
ORE and serum PSA levels. If PSA levels were >4ng/ml or abnormal ORE was assessed on 
exam, TRUS guided prostate biopsy was recommended. Due to the PSA lowering effects of 
Finasteride, there was a potential for detection bias in the control group since higher PSA levels 
are more likely to result in referral for biopsy. To minimize this potential bias, PSA levels in the 
7 
Consequently, this potential preventive strategy is undergoing further study in the 
REDUCE trial. This international, multi-center, double-blind, placebo-controlled 
chemoprevention trial is designed to determine if the 5-alpha reductase inhibitor, Dutasteride, 
decreases the risk of prostate cancer in high risk populations (11 l. A race stratified analysis was 
not conducted and the small sample size (n=298; 3.3%) was insufficient to power a subgroup 
analysis. Therefore, these study results may not be generalizable to African American men as a 
whole. Given this shortcoming of the previous study, REDUCE researchers have indicated that 
they intend to make a strong effort to recruit this high risk group. 
Given that the etiology of prostate cancer is poorly understood, primary prevention of 
prostate cancer will be challenging. However, with the high incidence of prostate cancer and 
the high morbidity and mortality associated with its treatment, primary prevention of prostate 
cancer serves as a particularly attractive option and remains an area of interest in prostate 
cancer prevention research. 
Vitamin and Mineral Supplementation 
Overall, the current data on vitamin and mineral supplementation and the primary 
prevention of prostate cancer is largely weak and inconsistent (12l· (13l· (14J Much of the available 
data on primary prevention of prostate cancer are based on secondary analyses. 
Alpha Tocopherol was studied in the primary prevention of prostate cancer due to its 
antioxidant properties. The Alpha Tocopherol and Beta Carotene Study (ATBC) trial was 
developed to study the effect of alpha tocopherol and beta-carotene on lung cancer incidence in 
male smokers between the ages of 50 and 69. The study was a randomized, double-blind, 
placebo controlled trial that found no overall effect on lung cancer, however it found that alpha 
tocopherol and beta-carotene was associated with a reduction in prostate cancer incidence(12l . 
This finding prompted a secondary analysis. This analysis revealed a 32% decrease (95% Cl:-
47% to -12%) in prostate cancer incidence in the alpha-tocopherol supplementation groups (13J 
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Consequently, there are new randomized controlled trials underway that look at prostate 
cancer prevention as a primary outcome. The Selenium and Vitamin E Cancer Prevention Trial 
(SELECT) and Physician Health Study II (PHS-II) are two such trials. The SELECT trial, which 
began enrollment of 35,000 men in 2001, will examine prostate cancer incidence as the primary 
outcome in healthy men receiving Vitamin E and Selenium supplementation or placebo. The 
final study results are expected in 2013 c15) The Physician's Health Study II (PHS-II) which is 
slated to end in December 2007, is another study that looks at the efficacy of vitamin C, vitamin 
E, beta-carotene, and a multivitamin in the primary prevention of cardiovascular disease, total 
cancer, and prostate cancer cnl_ The PHS-II study enrolled 16,743 physicians in the study and 
will likely give us some answer in the next year. Given the studies available, it is difficult to 
identify the strategy with the most potential benefitC10l. The ongoing SELECT trial and the 
Physician's Health Study II may help shed light on this ongoing debate. 
Secondary Prevention Strategies 
The aim of prostate cancer screening is to identify low stage prostate cancer in 
asymptomatic men, at a stage when the disease may be most treatable C16l. However, it is 
unclear if early detection of prostate cancer is of beneficial. The natural history of prostate 
cancer is heterogenous. Most prostate cancers are slow growing, low grade neoplasms that 
remain within the capsule of the prostate gland. The men who develop these slow growing 
cancers typically die of other causes. However, other prostate cancers are rapidly growing, 
highly differentiated neoplasms that spread quickly. If these cancers are detected early, they 
are potentially more treatable. Currently, digital rectal exam (DRE) and Prostate Specific 
Antigen (PSA) are the two main secondary prevention strategies being utilized for the 
identification of early prostate cancers in asymptomatic men. 
DRE involves the palpation of the prostate gland for nodularity and abnormalities. If 
abnormalities are detected on DRE, men are typically given a PSA test. The PSA test is a blood 
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to determine the true benefit of prostate cancer screening in the reduction of prostate cancer 
related deaths and improvement of other health outcomes. 
Raising further questions, the large prostate cancer incidence to mortality ratio brings the 
benefit of early detection into question. Additionally, the various prostate cancer treatment 
options are not without risk. In fact, these treatments are often accompanied by urinary, bowel, 
and sexual dysfunction '19) Given the latent nature and variable natural history of prostate 
cancer, some men with harmless cancers will inevitably be treated and will needlessly be 
subjected to treatments known to lower quality of life in about 50% of men receiving treatments. 
Given this uncertainty about the benefits in the face of known harms, it is felt that men 
should be involved in the decision making process until additional researchers can learn more 
about the net benefits of screening. 
Summary of Primary and Secondary Prevention Strategies 
The efficacy of primary prevention methods in the prevention of prostate cancer is still 
unclear. The benefits of prostate cancer screening are still unknown and the limitations of our 
current screening methods are substantial. In addition, the known risks of treatment create 
challenges in determining who to treat and who to watch. The complexity of the prostate cancer 
screening decision is reflected in the lack of consensus among professional societies. 
Current Recommendations for Prostate Cancer Screening 
American Urological Association (AUA): Recommends that men _:::50 years old should be 
screened for prostate cancer with a combination of DRE and PSA to detect small cancers 
missed by the PSA test (PSA< 4 ng/ml). All men should participate in the decision making 
process '16) 
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study, the Prostate, Lung, Colon and Ovarian (PLCO) cancer screening study is a 16 year multi-
center randomized control trial whose major aim is to determine whether cancer screening 
reduces mortality in individual between the ages of 55 and 7 4. Multicenter randomized control 
studies such as the PLCO will hopefully help us determine whether a survival benefit exists for 
prostate cancer screening. 
Systematic Evidence Review 
Background 
Shared Decision making and Values Clarification 
Given that immediate answers to the uncertainties surrounding prostate cancer 
screening are not yet present and professional medical societies agree that patients should 
participate in the decision making process, we must develop strategies to empower all 
populations of men to make informed decisions. Prostate cancer screening is a perfect 
example of a decision that should be shared between the physician and patient. Shared 
decision making with educational videos and decision aids are essential in educating men on a 
screening decision that is best tailored to their prostate cancer risk and their beliefs and 
attitudes. Effective decision aids include clear information and instruments that incorporate 
individual risk profiles and personal preferences which increase their confidence in making 
medical decisions and decreasing their decisional conflict (24· 25· 29) 
Shared decision making is process whereby a patient and physician make joint health 
care decisions. According to Sheridan et al, this process requires that the patient understand 
their risk, susceptibility and the severity of the condition. It also assumes that the patient 
understands the screening process, the alternatives to screening and the risks, benefits, 
uncertainties, and limitations of the screening process. Effective shared decision making also 
necessitates patient consideration of the risks and benefits of screening, and an assignment of 
value that reflects their own personal preferences. Finally, shared decision making assumes 
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exercise by trained health care workers, thereby allowing the physician to move immediately to 
the discussion and decision making. 
Beyond the challenges and uncertainties surrounding health outcomes and satisfaction, 
it is the ethical duty of physicians to educate their patients, grant them autonomy and help them 
become informed consumers. 
Special issues in shared decision making for African American Men 
In addition to the traditional challenges of shared decision making previously discussed, 
African American men face additional challenges. There are sociocultural factors that influence 
when and how men seek medical attention. Poor access to care, lack of insurance and general 
mistrust of the health care system are all factors that limit opportunities for men to engage in the 
decision making process. In addition, African American men may have unique concerns that are 
not addressed in the decision making process. Consequently, non-traditional strategies with 
tailored decision aids (e.g. pamphlets, videos, posters) administered by non-traditional, non-
medical members of the community should be considered in order to more effectively involve 
these populations. 
Culturally Sensitive Decision Aids 
Effective decision aids take differences in cultural, ethnic, religious, and social beliefs 
into consideration '26l- ' 27) Hence, culturally-sensitive values clarification, a process by which 
people make decisions based on the values they place on the features of each decision option, 
also plays an important role in creating effective decision aids '26) 
A culturally sensitive intervention is defined as an intervention that takes the target 
population's ethnic, cultural and sociodemographic characteristics, experiences, norms, values, 
behavioral patterns and beliefs into consideration during its development, implementation and 
impact measurement (27) In recent years, the need for culturally sensitive health promotion has 
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systematic evidence review of qualitative work exploring prostate cancer related knowledge, 
values, attitudes and beliefs surrounding prostate cancer and prostate cancer screening. 
Objectives of the Systematic Review 
To determine the culturally based values, attitudes and beliefs that influence African American 
men in their decision to undergo prostate cancer screening as compared to White and 
Hispanics. 
Identification of Systematic Evidence Review Articles 
A MEDLINE and Psych Info databases were searched. The MEDLINE search was 
conducted on March 14; 2007, and the following MeSH terms were used: "African American", 
"mass screening/psychology", "health knowledge, attitudes, practice", "cultural factors", "social 
values" and "ethnology". The keyword "values" retrieved articles specifically addressing PSA 
results and therefore, the MeSH term "social values" was more appropriate. The search was 
limited to "English" language articles and "Human" subject studies. All studies addressing 
"Adult", "Middle Age: 45+" and "Male" were also included. Given the recent questions 
surrounding prostate cancer screening benefits and the new screening guidelines in 2000, it 
was felt that article that addressed the new screening deadlines would be most appropriate. 
Therefore, the literature search was limited to articles published since 2000. The final Medline 
search yielded 29 articles (Figure 2). Qualitative Studies about African American Men, 
White/Latinos, Prostate Cancer and Screening, Culture or Cultural Factors, Knowledge, 
Attitudes and Values were included (Figure 1 ). Non-English articles that had one ethnic/racial 
group, focused on cancers other than prostate cancer, prostate cancer treatment decisions, 
genetic testing or prostate cancer study participation were excluded. Quantitative designs, case 
studies, case series, editorials or reviews were also excluded (Figure 1 ). 
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The use of fair dealing and grounded theory was also evaluated. A qualitative study that 
utilizes grounded theory collects themes and theories from the dataset, rather than using a pre-
existing theory'69 >. This is thought to contribute to existing knowledge more so than using one 
existing theory as the foundation of the study. Fair dealing utilizes existing theories. However, it 
uses different theories to ensure that different viewpoints are incorporated into the study design 
and interpretation of data '68>. 
Sampling and the description of data collection and analysis were also carefully 
appraised to determine whether selection bias presented a threat to the internal validity. All 
articles were evaluated to determine whether purposive sampling was utilized to reduce 
selection bias and increase external validity, The use of multiple coding, a method of assessing 
agreement of coding between coders, was checked to determine the level of inter-rater reliability 
'
67>. The presence of triangulation, a technique that uses different methods of data collection to' 
answer one focused question, was also assessed. Triangulation is often used to confirm or 
refute internal validity however this technique is difficult to perform and is more likely to refine 
study findings '67>. 
The study context was also evaluated to determine whether the setting can be 
generalized to other populations in different settings. To ensure that all ideas were collected 
from the target population, we checked each study to determine if thematic saturation was 
achieved. Lastly, the presence of respondent validation was assessed to determine whether the 
study participants agreed with the researchers' interpretation of their interview responses. 
Results 
Meade et al (20o3r 
In 2003, Meade et al conducted a focus group based qualitative study in a community 
setting in Tampa, Florida. They sought to determine the everyday priorities and concerns, 
prostate cancer knowledge, attitudes and beliefs and learning preferences. The study included 
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community based grass roots organizations and other community sites throughout the Tampa 
area. This served to reduce selection bias and increase the ability to generalize the results 
across populations. An additional strength of the study was the use of a different cultural group. 
Although you cannot do head to head comparisons in unstructured interview setting, the 
inclusion of a different group contributed additional viewpoints. 
Although focus group sample sizes are typically small, it serves as a weakness. The 
recruitment of a small group of men from one region, with a relatively low SES, and low levels of 
education is not representative of African American and Hispanic men in this country. Further 
study with larger groups of African Americans and Hispanics from different regions of the US will 
be necessary to improve the generalizabilty of the results. 
The age range is also problematic given that prostate cancer is a health concern for 
middle aged and older men. The purpose of including younger men in the study was to 
determine how health information was obtained and viewed across generations. However, the 
results were not reported in this manner. Younger men who will not be faced with this decision 
for another 20 or 30 years may have biased attitudes and beliefs compared to the older men in 
the study. It was also unclear whether, data saturation, the recruitment of participants until all 
new ideas are obtained, was achieved. 
Finally, three African American men (8.8%) with a history of prostate cancer were 
included in the study. This is a potential source of bias for a few of reasons. Men who have 
prostate cancer or have been successfully treated for prostate cancer will have different 
attitudes and beliefs regarding prostate cancer because they have experienced the disease. So, 
the reader would need to be made of aware of comments made by these men as their 
comments will be biased by their personal experiences. Meade et al did not make this 
differentiation when they reported their results. In addition, the men with histories of prostate 
cancer were all African American men, so there were no cancer survivors in our comparison 
group (Hispanic men) to share any potential differences in their attitudes and beliefs. Lastly, 
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believed that early detection meant that "you have a good chance". White men agreed, adding 
that one can also "avoid impotence if you catch it early so they don't have to do drastic radical 
surgery". Hispanic men simply wanted to know. One Hispanic man said, "If I have something, I 
want the doctor to tell me ... then I know in advance". 
All groups seem to have mixed feelings regarding the question of shared decision 
making. African American men felt as if their doctors "won't tell you anything that you ask them". 
White men felt that "most doctors won't explain it. They never have time". 
Overall, it appeared that lack of knowledge and unrealistic beliefs surrounding the utility 
of prostate cancer screening were major themes for all three groups. These misconceptions 
were prevalent across racial groups. Beliefs, thoughts and opinions regarding the actual 
prostate cancer screening exams (DRE/PSA) were not discussed or reported. 
Quality, Strengths and Weaknesses 
The overall quality of the study was good. The internal validity was good, but the 
external validity was poor. The strengths of the study included recruitment of three racial/ethnic 
groups, which allowed comparative inference. The focused clinical question was clear and 
relevant for our systematic review. They utilized grounded theory, increasing the potential for 
new theory and further insight into existing information obtained from past studies. The design 
was appropriate and the data collection and analysis was clear and easy to follow. McFall and 
colleagues utilized multiple coding to improve demonstrate inter-rater reliability. However, 
triangulation was not utilized to confirm internal validity. 
The study weaknesses and limitations include the use of a convenience sample. This 
reduces external validity and introduces selection bias. Study participants were recruited from a 
health care setting reducing the generalizabilty of the study. These men are potentially more 
knowledgeable of the health care system, prostate cancer screening than the average American 
man. The use of a female moderator could have affected the validity of responses. Using a 
female moderator for a sensitive issue such as prostate cancer screening does not promote 
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African American and Hispanic participants. One African American man said he felt as if "your 
manhood has been compromised". There was also concern about homosexual tendency" in the 
African American group. In addition, some African American participants expressed "fear and 
embarrassment" regarding prostate cancer screening. Hispanics had similar feelings. One 
Hispanic man said, "it's a disgrace". Some expressed that "it makes us embarrassed". 
The physician-patient relationship was also a recurring theme during the focus group 
interviews. Non-Hispanic White men and Hispanic men in the study did not like going to the 
doctor. One White man said, "Guys don't like to go to the doctor." A Hispanic man said they 
"don't go to doctors", instead they try to manage their symptoms on their own and may consult 
community healers ( Curanderas) prior to consulting Western medicine. Therefore it is important 
that information regarding prostate cancer and screening be made widely available outside of 
the traditional health care setting. 
All men agreed that they should talk to their doctors about the test. One White man said 
he had "blind faith in his doctor" but sometimes there is a failure to communicate. One Hispanic 
man was confused at the notion that "respected doctors disagree [on screening]". African 
American participant felt that "there are a lot of myths" and that speaking to your physician was 
a good solution. However, African American men expressed distrust for physicians. Overall, all 
men felt that there was a lot of uncertainty and communication should improve. 
Hispanic men felt that culturally sensitive brochures should include information about the 
anatomy of the prostate. In describing the prostate, each group of men preferred different 
language. African American men preferred "ping pong ball", Hispanic men preferred "lime", 
whereas White men preferred "walnut". Hispanic and African American men wanted to know 
more about risk factors and whether diet and exercise played a role. White men felt it was 
important that men know that early prostate cancer can be asymptomatic. Hispanic men wanted 
to know the symptoms of advanced disease. African American men felt it was important that 
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as opposed to the complete strangers (as in the McFall study). Lastly, the study sample size 
was small. 
Researchers used a convenience sample from a health care setting, resulting in two 
problems. This reduces external validity and therefore the generalizabilty of the study. Secondly, 
this introduces selection bias. The men are potentially more knowledgeable of the health care 
system, and prostate cancer screening than the average American man. Purposive sampling 
was not utilized, so men from different regions, socioeconomic backgrounds and different 
settings were not likely represented. This reduces the ability to generalize these results to other 
men across the country. Lastly, it was unclear from the short study description whether data 
saturation was achieved. 
Nash et al (2002)69 
Nash and Hall conducted a qualitative study to assess knowledge, attitude and beliefs 
about prostate cancer in African American and White men. Nash et al conducted open-ended 
focus group interviews based on the Health Beliefs Model. African American and non-Hispanic 
White men, ages fifty and over were recruited using purposive sampling from a University 
setting in Arkansas. A total of 37 total men were recruited for the study ( 11 urban White men, 1 0 
rural White men, 8 urban African American men and 8 rural African American men). The mean 
age was 62 years old. By group, mean age was slightly lower for African American men ( 45.5 
for Urban African Americans, 45.7 for rural African Americans, 51 for Urban White men and 54.5 
for Rural White men). Most men had at least a high school education (82% of urban white men, 
80% of rural white men, and 75% of rural and urban African American men). 
Results (Table 3) 
In the study, major themes arose when the focus group questions were presented. 
Knowledge was an important theme. Although most men were familiar with prostate cancer, 
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and relevant for our systematic review. For their interview guide, they utilized an established 
theory in the development process. the health beliefs model. increasing the validity of study 
results. The research design was appropriate. Nash used purposive sampling to reduce 
selection bias and increase external validity of the results. 
The study weaknesses and limitations included the short. non-detailed description of 
the data collection process and analysis. It was unclear if Nash and Hall performed multiple 
coding to demonstrate inter-rater reliability. Even so, they did not report the percentage of 
agreement between coders. Also. the study sample size was small, although purposive 
sampling was performed to reduce selection bias and increase generalizability. So men from 
different socioeconomic backgrounds and different settings were likely represented to some 
extent. Lastly, it was also unclear from the study description, data saturation was achieved. 
Conclusions across studies 
Overall, a few recurring themes were identified in the study. There were five dominant 
themes that seem to recur in the majority of articles identified in the systematic evidence review. 
These five themes described below. were found to influence the prostate cancer screening 
attitudes, beliefs and health behaviors of all men. Some themes were found to be more 
influential to a particular racial/ethnic group than others. 
Lack of Knowledge 
Knowledge was a common theme among the articles identified in the systematic 
evidence review. Lack of knowledge regarding the prostate, prostate cancer risk factors. the 
presentation of early and advanced disease, prostate cancer screening methods, prostate 
cancer treatment and treatment side effects was common among all three racial groups. In the 
systematic evidence review. African Americans were slightly more knowledgeable about 
prostate cancer risk factors and their increased risk of developing and dying from the disease. 
This finding is thought to be secondary to targeted efforts to inform African American men and 
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access and health care utilization (66>. However, the impact of baseline cultural differences and 
use of community healers (Curanderas) cannot be underestimated. 
African American men associated prostate cancer with poor prognosis and death. They 
also feared that they may not have access to treatment if they were to be diagnosed with 
prostate cancer. 
Family and Faith 
Family was a common theme in the systematic evidence review for all three groups. 
Men felt that they were the providers and needed to be there for their families. Men also felt 
pressure from their social support systems. Men reported that wives were particularly influential 
in encouraging health behaviors (66 >. Men also felt that they should be screened in order to place 
the needs of the family first. 
Patient Doctor Relationship 
Communication between the physician and patient was a common theme. Men felt that 
they needed to ask the doctor more questions, but the doctor was always rushed and simply did 
not have time. An African American study participant felt that doctors wouldn't take the time to 
answer the questions even if you did ask. Lack of trust for the health care system was also a 
common theme for African American and Hispanic men. All three groups agreed that 
communication should improve. Hispanics and African Americans felt that community outreach 
through community leaders, and cancer survivors would more effectively deliver the intended 
message. 
Future decision aids should not only function to improve knowledge for these groups, but 
to dispel myths. For African American and Hispanics men, decision aids should address these 
questions of homosexuality, loss of dignity and humiliation. Physicians should better 
communicate with patients about the screening exams, their purpose and what they entail. 
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Qualitative methods, such as focus groups and interview methods have other inherent 
problems. These qualitative methods can also weaken the validity of the study results. They do 
not allow direct comparison of groups. Sample sizes are typically small, so representative 
samples are unusual. However, performing purposive sampling and achieving thematic 
saturation can help researchers avoid these threats to internal validity. 
Lastly, quality rating in qualitative studies is a challenging task. Consequently, efforts 
have been made to apply quantitative measures of quality, such as internal validity, external 
validity and reliability, to qualitative research. The end result has been the creation of a number 
of quality checklists, however, these quality checklists have not been validated, r68· 69•77• 78J 
These checklists were not created to confer rigor, but to help improve rigor in qualitative studies 
r68l. Hence, satisfying these checklists does not automatically confer validity and rigor upon a 
qualitative study. Readers must critically appraise the use of these technical methods to ensure 
that they have been adequately applied. Even then, quality rating must be made and interpreted 
with caution. The quality rating assigned to the SER articles used in this study are all based on 
these non validated checklists. Hence, the quality ratings assigned to each study cannot be 
assured. Overall, this weakens conclusions of the systematic evidence review quality ratings. 
Research Design 
Introduction 
For my research study, I plan to apply the systematic evidence review findings in the 
development of my interventions. The systematic evidence review was valuable in identifying 
common themes that resonated among three different racial/ethnic groups. These themes will 
be used to develop the culturally tailored interventions for the proposed research study. They 
will be incorporated into study educational videos and values clarification exercises. The 
ultimate goal will be to effectively increase knowledge, identify important values, attitudes and 
beliefs, engage men in the decision making process and reduce decisional conflict. 
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The second category is intuition enhancing strategies. These are also valuable methods 
of clarifying values and reducing decisional conflict. These exercises attempt to dismantle 
organized thought and allow for the free flow of ideas and self confrontation(53>· Social matching 
could be seen as an exercise in self-confrontation that allows the patient to see a situation from 
two different perspectives. Values clarification exercises are potentially effective methods of 
helping patients make their decisions about prostate cancer screening. According to Krist, 
"Even if a clear benefit to screening was found, value uncertainty would persist-- a trade off 
versus benefit, the magnitude of each inherently dependent on individual values." (so) Volk et al, 
concluded education helps increase knowledge, but does not effectively help clarify values (s•>. 
The ranking and rating exercises used in this study design will serve to present the issues and 
help men place value on each one. 
Focused Clinical Question 
Research Design Overview: 
Design: Randomized Controlled Trial+ Post Trial Focus Group 
Focused Question: Do culturally tailored decision aids effectively increase knowledge, reduce 
decisional conflict and identify values, attitudes. beliefs and preferred role in decision making, 
compared to neutral decision aids and no decision aid? 
Secondary Question: Do culturally tailored decision aids influence intent to have prostate 
cancer screening. screening behavior at 6 months. satisfaction with screening, and final 
screening behavior? 
Population: African American, White and Latino Men, 40- 80 years of age 
Intervention: Culturally Tailored Educational Video+ culturally tailored values clarification 
exercise. 
Comparison: Neutral Educational video + neutral values clarification exercise 
Comparison 2: No prostate cancer screening related educational video + no prostate cancer 
screening related values clarification. 
Outcome. Primarv: (1) Determine whether prostate cancer knowledge improved, 
(2) determine whether decisional conflict was reduced, (3) determine values, attitudes. and 
37 
participants call, their eligibility will be determined. If they are eligible, appointment for study 
participation will be scheduled. 
Administration of the Intervention and Surveys 
The study will have three arms. Eligible men who agree to participate will be randomized 
to (1) the appropriate computer based culturally tailored educational video and ranking and 
rating values clarification exercise, (2) a computer based neutral educational video on prostate 
cancer, screening and treatment and a ranking and rating values clarification exercise or (3) 
computer based "no education" exercise (Figure 5). 
The intervention will take place in three parts. First, study participants will complete 
computer based surveys (pre and post intervention). Second, study participants will review the 
educational video and complete a values clarification exercise. Finally, study participants will 
complete post-intervention surveys immediately after the intervention and at follow up 6 months 
post intervention. This 6 month follow up survey will be mailed to them via US mail. The study 
interventions and related surveys will be administered at the local library. This site will provide 
five small rooms with computers, where the participants can complete their surveys, watch their 
videos and participate in the focus group sessions. Computers and headphones will be 
available in each room. 
At their study visit, participants will first complete their surveys, watch their assigned 
educational video and complete their values clarification exercise on the computer. Computers 
will be used in this study to address literacy issues. Headphones will be made available with 
every computer. Survey questions, values clarifications exercises and instructions will be read 
aloud through the headphones. Two member of the research team will be available in each 
room to give instruction and assist study participants. 
39 
The educational videos will last about 30 minutes and highlight topics from prostate 
cancer, screening methods, screening options (ORE and PSA), misconceptions, patient-
physician relationships and other culture specific themes that arose in past studies (Table 3). 
The first portion of the video will consist of narrated information with images and graphs to 
educate men on anatomy, culturally tailored statistics, and prostate cancer facts (symptoms, 
screening options, and diagnosis and treatment options). The second portion of the video will 
feature a dramatization of four men currently in the decision making process, discussing their 
differing views, attitudes and beliefs regarding prostate cancer, screening and treatment. Their 
discussion will feature their free flowing thoughts, brainstorming process and the logic 
surrounding their decision. Men will be instructed to listen carefully and identify which character 
most represents them and why, a process known as social matching. The question will appear 
on the screen after the educational video is complete. 
After the educational video, study participants will participate in a computer based 
ranking and rating exercise. Participants will be given four statements corresponding to a 
particular topic (i.e. health status, religious views, patient-physician relationship status, prostate 
cancer screening exam, family support etc.). They will then be asked to choose the statements 
that most represent their opinion or beliefs. They will be given the option adding to this 
statement in order to further customize the statement to their personal values. This will serve to 
reduce the limitations of ranking and rating, allowing us to uncover additional value conflicts that 
we may not have anticipated. They will then be asked to rate the importance of each topic 
(corresponding to the statement they chose in the first part of the exercise) on a scale from 1 to 
10. Finally, participants will be asked to briefly type why they chose the options they chose in 
the exercise. Upon completion of the exercise, the men will complete the computer based post 
intervention surveys and participate in a short focus group session to give intervention 
feedback. 
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to obtain intervention feedback. 
Control Group 
No Education Group 
The participants in the control group or the "no education" group will watch a neutral 
video about the history of American football. They will also complete a non-prostate cancer 
related social matching exercise and a computer based values clarification exercises ranking 
and rating the importance of family, work, leisure activities and hobbies. Study participants will 
be given four statements corresponding to a particular topic and asked to choose the 
statements that most represent their opinion or beliefs. They will then be asked to rate the 
importance of each topic (corresponding to the statement they chose in the first part of the 
exercise) on a scale from 1 to 10. To complete the exercise, participants will be asked to briefly 
write why they chose the options they chose. Lastly, the group will complete the same computer 
based post-intervention survey completed by the other groups. They will also be asked to 
participate in a short focus group session conducted by members of the research team to obtain 
intervention feedback. 
Randomization 
A computerized random-number generator will be used to randomize subjects in a 3:1:1 
fashion to the culturally tailored intervention, neutral education intervention group or the "no 
education" control group, respectively. Randomization will be done within race strata to ensure 
that equal numbers of men in each racial group are randomized to each study arm. We will use 
a computer generated random number scheme with blinded allocation to control (no education) 
and intervention groups (culturally tailored and neutral education) to ensure adequate 
randomization. Group assignments will be sealed in a security envelope until the telephone 
eligibility assessment. 
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Data Analysis 
Sample Size Calculation 
The sample size for the pilot research study will draw from calculations performed by 
Sheridan et a! in a pilot study to assess decision making with PSA testing. A conservative 
average mean difference of 0.40 will be used in the decisional conflict scale. This will be based 
on the difference between those who made a decision and those who delayed their decision in 
decisional aid intervention studies for various preventive conditions <33>. This effect size is 
similar to the changes observed in the decisional conflict scales in those who received a 
decision aid intervention for prostate cancer screening and those who did not in a previous 
decision aid study, providing validation for this approach <34>. 
A decisional conflict score of 2.0, a standard deviation of 0.6, a two-sided alpha of 0.025 
and a power of 90%, will be used to determine the sample size and the number of participants 
needed in each group to detect a difference in the decisional conflict score between the 
intervention and control group using a Wilcoxon Rank Sum test. 
Statistical Analysis 
In order to assess the effects of the values clarification interventions, the intervention 
and control groups will be compared with respect to decisional conflict score means. If 
necessary, we will control for any baseline variables that are not similar between groups using 
linear or logistic regression models when appropriate. Intervention and control groups will also 
be compared to determine the differences in the proportion of participants who decide to be 
screened using the intent to be screened instrument in the pre-intervention, post intervention 
and 6 month follow up survey. We will use an intention to treat analysis. 
To determine whether participant characteristics (including age, education, health status, 
socioeconomic status, preferred role in decision making and patient knowledge etc.) correlate 
with any of the primary and secondary outcomes, we will create exploratory models to assess 
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responses, as the educational video may potentially increase knowledge and influence men's 
decisions to participate in the decision making process. 
Knowledge: 
I would expect the knowledge score to be low for all groups. I do not expect a statistical 
difference between groups. Men will likely be more knowledgeable in different areas, based on 
their experiences. For example, African American men will probably be more likely to know that 
family history and race are risk factors for prostate cancer because they are directly affected by 
this fact. However, I do not anticipate a statistically significant difference in knowledge between 
groups by race, but I do expect the two educational video groups to have significantly higher 
prostate cancer knowledge in the post-intervention survey as compared to the "no education 
group". It would be interesting, to look at differences between other characteristics such as level 
of education, income or insurance status. 
Secondary outcomes of interest: 
Intent to be screened: A statistically significant difference between the culturally 
tailored, neutral and no education group is not expected due the weight carried by individual 
values in this decision. It is difficult to make a prediction, because decision aids can improve 
knowledge, encourage men to participate in the decision making process without increasing 
their anxiety (36l. However, properly constructed decision aids are unbiased and utilize balanced 
framing in the presentation of the known harms, benefits, uncertainties and limitations. The 
decision to be screened is utility sensitive and therefore the value placed on the harms, benefits 
and limitations of screening is personal and will vary from individual to individual based on their 
values, experiences, preferences for outcome of treatment and preferences for quantity of life 
versus quality of life (43• 44l· Therefore, the participants' final decisions should not be predictable. 
Seven trials have measured screening behavior following administration of decision aids 
meant to promote informed decision making. Three of these studies reported reduced 
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Discussion 
Prostate Cancer is a disease that affects men of all races and walks of life. However, it 
affects men of different races to differing degrees. African American men are 2.4 times more like 
to be affected than White men. Questions regarding the benefit of screening have prevented 
unified recommendations from medical experts, further increasing the complexity of the 
screening question. Studies that should give us important answers such as, the European 
Screening Research Study and the PLCO study, are still underway. Medical experts and the lay 
public alike are waiting in anticipation for the completion of these studies in hopes of the long 
awaited answer to the prostate screening debate. As we wait, we must find more effective ways 
to implement the current recommendation of shared decision making. 
Knowledge and the personal awareness of values appear to be important components of 
the patient's decision making process. With challenges ranging from lack of time, lack of 
knowledge, poor access to health care to fear of the health care system, it becomes difficult to 
educate and involve patients in the decision making process. The systematic evidence review 
(SER) was valuable in elucidating some of the barriers and concerns that men of different races 
face when they are making decisions regarding prostate cancer screening. The themes that 
were uncovered in these studies were instrumental in creating our research design. The 
themes will be incorporated into the values clarification exercises, survey questions, interview 
guides as well as the educational video. 
The SER made us aware that all groups were lacking in prostate cancer knowledge. It 
also made it clear that prostate cancer is perceived negatively by men of all ethnicities, however 
White men felt more positively about the possibility of cure. Hispanic men appeared to be more 
fatalistic, whereas African American men were more negative about prognosis. Screening with 
ORE was an issue for all groups due to pain and discomfort. However African American and 
Latino men were also strongly opposed to the screening test due to feeling of violation and 
questions of homosexuality. Poor relationships with physicians resonated with all groups, 
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address the individual concerns of each racial group may be an effective strategy. It is also 
possible that a multicultural intervention that addresses all unique concerns of each ethnic/racial 
group in one video or pamphlet may be most effective. 
Strengths and Limitations 
Our research design suggests an effective way of determining whether culturally tailored 
decision aids that incorporate men's preferences will make a difference in level of prostate 
cancer knowledge as well as reducing decisional conflict by addressing men's values, attitudes, 
and beliefs about prostate cancer and screening in an efficient manner. The strengths of this 
study design include a clear, focused clinical question. Given the growing number of men 
entering their 40s and 50s, prostate cancer will continue to be an issue of concern among 
medical experts and the public. Hence, the clinical question is clear and relevant. The design of 
the research study is appropriate. Men will be randomized and split into groups by race in order 
to determine if there are any differences in prostate cancer knowledge, values, attitudes, beliefs 
about prostate cancer and screening and decisional conflict after no education, a neutral 
intervention or a culturally tailored intervention. The inclusion of men of the three races most 
affected by prostate cancer will strengthen the study. This study will likely give us insight into 
culturally based health beliefs and health behavior, which will give us information on which to 
build on new theories or information to refine and develop existing ones. Lastly, the inclusion of 
a no education group will help us determine whether any of the educational videos were 
effective in improving knowledge and reducing decisional conflict. 
In our focus group, the use of purposive sampling is a strength. This will serve to reduce 
selection bias and increase ability to generalize the results to a larger population. Multiple 
coding, which is used to assess for inter-rater reliability, will also serve to reduce measurement 
bias and increase internal validity of the study. The use of male moderators will also serve as a 
strength. Same gender moderators will likely serve to increase the probability of receiving open 
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curaraderas to address gaps in knowledge. Physician extenders should be trained to assist 
physicians in educating patients, answering questions and addressing concerns. Images on 
brochures and educational videos should reflect the intended audience, facilitating the 
audiences' ability to identify with the characters. Our research study will further elucidate the 
effectiveness of culturally sensitive decision aids and will help us further refine the content of the 
ideal prostate cancer decision aid. 
Future studies should take a look at age specific concerns. Age specific educational tools 
may help address some of the concerns younger versus older men face when deciding whether 
or not to be screened for prostate cancer. In addition, future studies with a larger sample size 
should look at level of education and prostate cancer knowledge. The challenge with this 
question is that income and insurance status are difficult to separate, therefore it will be 
necessary to control for income and other SES markers. 
Future studies should also look at the role of literacy and attitudes, beliefs about prostate 
cancer. Level of education and literacy may play a larger role in lack of prostate cancer 
knowledge and desire to participate in the decision making process than race and ethnicity. 
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Table 1. Focus Group Interview Guides 
Author, Title Focus Group Questions/Interview Themes 
Chan EC, Haynes MC et al 
(2003)66* !.) Prostate 
2.) Prostate Cancer and risk 
Cultural Sensitivity and informed 3.) Screening for prostate cancer 
decision making about prostate 
cancer screenmg 
McFall, Hamm and Yolk 
(2006)64* I.) Risk and causation 
2.) Signs and symptoms 
Exploring beliefs about prostate 3.) Awareness of screening controversy 
cancer and early detection in men 4.) Shared decision making 
and women of three ethnic groups. 
Meade, Calvo et al (2003) 54 Life and Family 
• What are the three most important things in your life 
Focus Groups in the design of Issues, Problems, Concerns 
Prostate Cancer Screening 
• What are your biggest problems facing you? 
Information for Hispanic Farm Health 
workers and African American Men 
• What should be done to stay healthy? 
• Where do you go when yon are sick? 
• Do you go to that person when you are healthy? 
Cancer Screening/Treatment 
• When you think of cancer, what three things come to mind? 
• Do you know anyone who has ever had cancer? Who? 
• What do you think can cause cancer? 
• Where can people go to find out if they have cancer? 
• Do you think cancer can be cured or treated? 
• What do you know about prostate cancer? 
• How do you think people you know would feel about having PSA/DRE 
done? 
Sources of Information 
• How did you learn about cancer? 
Nash and Hall (2002)"" Focus Group Interviews. Interview guide based up the Health Belief Model. 
Prostate Cancer in Arkansas. Individual Perceptions: 
• General Health 
• Cancer in General 
• Prostate Cancer 
Knowledge: 
• Sign, Symptoms, Prevention 
• Early detection, Screening 
• Treatment, Side Effects 
• Awareness of Social Norms 
Modifying Factors: 
• Internal Cues to Action 
• External Cues to Action 
• Other Barriers 
Likelihood of Action: 
• Health Maintenance/Promotion 
*Themes were addressed. However, focus group interview questions were not included in the article. 
Table 2. Quality Rating 
Quality Scale: 
+++ Excellent ++112 Very Good 
++ Good +112 Fair 
+ Poor 
Relevance68 +++ +++ ++ 1/2 +++ 
Clarity of Research Question +++ ++1/2 +++ ++ 
Design appropriateness ++1/2 +++ ++1/2 +++ 
Purposive Sampling67 I 
NO, NO YES, YES, 
Convenience Convenience Purposive Theoretical 
+ + +++ +++ 
Clear description of Data I +1/2 +++ +++ +1/2 Collection and Analysis 
Triangulation68/ YES, 
I 
I 1-'-'! 
I 
NO 
I 
No triangulation 
Multiple Coding67 Multiple Coding Multiple Coding + Multiple coding?? ++ ++ 
Grounded Theory67 1 Grounded Theory Grounded Theory Grounded Theory I No, HBM Fair Dealing68 +++ +++ +++ ++ 
External Validity + + ++ I ++ 
Respondent Validation67 NO NO YES I NO ++ + + + 
Overall Rating* 
+1/2 + 1/2 ++1/2 I +1/2 
Grounded Theory: Alleges that all theories are derived from the dataset rather than using prior theoretical viewpoints. 
Fair Dealing: Research design explicitly incorporates a range of different perspectives to avoid having one viewpoint represent any scenario."' 
Table 3. Descriptive studies that address reasons why African American men do not undergo Prostate Cancer 
Screening. 
HaynesMC et 
al (2003)66 
Jniversity Setting, Focused Clinical Question: 
Focus Group I University of Texas- How would African Americans, Caucasians and 
Houston Hispanics want information regarding Prostate 
Cancer screening (DRE and PSA) presented in 
culturally sensitive brochures? 
AAMen(n~5) 
White Men (n~5) 
Hispanic Men (n~lO) 
(Ages :0:50, married) 
Mean age: 62 
AA: 65 
White: 63 
Hispanic: 60 
Results from Focus Group Interview Guide: 
Caucasians: 
Physician-Patient Relationship: 
"guys don't like to go to the doctor" 
"blind faith in any doctor" 
failure to communicate about details of the DRE: 
"my doctor doesn't say a word, just drop your 
pants" 
"talk to your doctor about it" 
African Americans: 
Machismo 
"your manhood has been compromised" 
"fear, embarrassment" 
"homosexual tendency" 
Physician-Patient Relationship: 
"there are a lot of myths" 
"should discuss this with their doctor" 
Latinos 
Machismo: 
"it's a disgrace" 
''makes us emabarrassed" 
Physician-Patient Relationship: 
"respected doctors disagree" 
"we don't believe in screening" 
"don't go to doctors" 
Common themes: 
Lack to desire to visit the doctor's office 
unless acutely sick. 
uverau (,luaury: Fair 
Internal Validity: Fair 
External Validity: Poor 
Strengths: 
I. Recruitment of different 
racial/ethnic groups-comparative 
study 
2. Inclusion of 3 ethnic groups 
3. Multiple Coding 
Weaknesses: 
I. Small Sample Size 
2. Small geographic region 
3. Convenience sample: No 
purposive sampling 
4. Inter-rater Reliability- not 
reported 
5. Poor external validity 
6. There was no clear description of 
data collection and analysis. 
7. No mention of whether 
data/thematic saturation was 
achieved. 
8. Did reflexivity occur?? 
9. Did respondent validation occur? 
Meade, Calvo, 
Rivera, Baer 
(2003) 54 
Focus Group 
Community based 
setting 
Tampa, Fl 
African American and 
Hispanic Men Age 2:18 
(n=71) 
2 Hispanic Focus 
Groups 
(n= (37) 
2 African American 
Focus Groups 
(n= 34) 
Ages: 18-85 
Mean Ages: 
AA: 50 (22-85) 
Hispanic: 38 (18-67) 
Focused Clinical Question: What are the 
important daily issues, cancer and decisions to get 
screened? 
Results from Open ended interview guide: 
Major Themes: 
Hispanic Men: 
Knowledge: 
• Lack of Knowledge 
• Anatomy, risk factors, screening options 
Prostate Cancer: 
• caused by contagious infection, 
promiscuity, excessive sexual activity, 
rusty nails 
• Fear, Death 
• Denial: "I try not to think [about it}.. " 
Prostate Cancer Screening: wl DRE 
• "I feel embarrassed" 
• "only if there was no other option" 
• By a doctor"one who is dignified" 
• Other barriers: Lack of access to care 
• Important influences: Religion, Family 
Health Care Access/Dr.-Pt relationship: 
• Only go to the doctor if very sick 
• Lack of trust for the health care system 
• "I don't believe a lot of what doctors say" 
• "There are doctors that lie, they're 
corrupt people" 
• Who delivers the message: 
Source of health care information: 
• prefers cancer survivors, patients w/ 
cancer, physicians, community members, 
schools, and media (radio, tv, newpaper) 
Overall Quality: 
Internal Validity: Very Good 
External Validity: Fair 
Strengths: 
!. Second Racial/Ethnic group 
2. Recruited other racial/ethnic 
groups 
3. Grounded Theory 
4. Clear description of data 
collection and analysis 
5. Appropriate design 
6. Clear research question 
7. Purposive Sampling 
8. Respondent Validation through 
community leaders 
Weaknesses: 
!. Age Range (18+) 
2. Small sample size 
3. Recruited from one region 
4. Did not include non-Hispanic 
White Men 
5. Included men with history of 
prostate cancer (8.8 % of AA 
study participants, no Hispanic 
men) 
6. Multiple coding not performed 
7. Inter-rater reliability not reported 
8. No Triangulation 
9. No mention of whether 
data/thematic saturation was 
achieved. 
10. Reflexivity?? 
Focus 
Groups Sample size n=37 
Rural White Men 
(n=lO) 
Urban White Men 
(n=ll) 
RuralAAMen 
(n=8) 
UrbanAAMen 
(n=8) 
5 focus group (n=8-l 0) 
Stratified for ethnicity 
and rural vs. urban) 
Ages: ::: 40 yrs old 
Mean ages: 
Urban AA: 45.5 
Rural AA 45.7 
Urban White: 51 
Rural White: 54.5 
Focused Clinical Question: What are 
knowledge, beliefs about prostate cancer of African 
American and White men in an urban vs. rural setting? 
Interview guide based up the Health Belief Model 
Caucasians- Urban 
Prostate Cancer Knowledge: 
• Limited 
Prostate Cancer: 
• Perceived negatively: Once you feel bad, it's too late 
• Gen.etic 
• Frequent sex prevents prostate cancer 
Screening: 
• Identified PSA and "finger test" 
• "discomfort" ''embarrassment" 
• Fear of test and results 
• Other barriers: Time, opportunity cost, Laziness 
• Influenced by doctors (limited), spouse, media, lay 
persons 
Treatment: 
• Alternative medicines (e.g. saw palmetto) 
• Side effects: Incontinence 
Patient Doctor relationship: 
• Lack of communication 
• "I don't go to the doctor unless I'm dying" 
Source of health care information: 
• Doctor (limited), spouse media, lay persons 
Caucasian- Rural 
Prostate Cancer Knowledge: 
• Limited 
Prostate Cancer: 
• Negative perception 
• Identified as major health concern that t with age 
• Possibility of cure: ''used to be death. Now it's an 
ordeal" 
Screening: 
• Identified PSA and DRE 
• PSA screening inaccuracy 
• Uneasiness with DRE ( with joking and laughter) 
• Other barriers: Financial barriers and health 
insurance coverage 
• Influenced by experience of others 
Treatment: 
• Alternative medicines (e.g. saw palmetto) 
• Surgery 
Patient Doctor relationship: 
• No comments 
Overall Quality: Fair 
Internal Validity: Fair to Poor 
External Validity: Fair 
Strengths: 
1. Comparison Group: included 
White and African American men 
2. Rural vs. Urban group, increases 
generalizability/transferability. 
3. Purposive sampling 
4. Focus Group 
5. Good description of context and 
study population. 
Weaknesses/Limitations: 
1. Poor description of analysis 
2. Unsure if Multiple coding was 
performed 
3. No Triangulation of data 
4. No fair dealing: One theory used 
as foundation (HBM) 
5. No grounded theory 
6. One Region: difficult to 
generalize 
7. Small sample size 
8. Unclear whether thematic 
saturation was achieved through 
participant recruitment and focus 
group sessions. 
9. Reflexivity?? 
10. Respondent Validation? 
Table 4: Descriptive Data 
Culturally Tailored Intervention Neutral Intervention Group Control Group 
(n=x) (n=x) (n=x) 
Mean age (range) 
Race: 
African American 
White 
Latino 
Education: 
Less than high school 
High school 
At least some college 
Marital Status: 
Single 
Married 
Divorced/ Widowed 
Household income: 
<$25,000/year 
$25,000 to $50,000/year 
>$50,000/year 
Insurance Status: 
No Insurance 
Medicaid 
Medicare 
Private 
Usual Source of Care: 
Yes 
No 
Family History of Prostate Cancer 
Yes 
No 
Previous Prostate Cancer 
Screening Counseling 
Yes 
No 
Table 5: Results 
Primary Outcomes No Education Neutral Education Cultural tailored Intervention 
Group 
African Latino White 
American 
Knowledge Score (mean) 
Decisional Conflict Score 
(mean with range) 
Values/Attitudes/Beliefs 
(Themes) 
Preferred role in Decision 
Making(%) 
Active 
Shared 
Passive 
None 
No Education Group Neutral Education Difference 95%CI 
(mean) Group 
(mean) 
Knowledge Score 
I 
Decisional Conflict 
Intent to be 
screened (%) 
No Education Culturally Tailored Difference 95% Cl 
Group Group 
(mean) (mean) 
Knowledge Score 
Decisional Conflict 
Intent to be 
screened (%) 
-------- --
Neutral Education Culturally Tailored Difference 95% Cl 
Group Group 
(mean) (mean) 
Knowledge Score 
Decisional Conflict 
Intent to be 
screened (%) 
Figure 1. Inclusion/Exclusion Criteria 
Articles about: 
1. African Americans 
2. Whites or Latinos/Hispanics 
3. Men 
4. Prostate Cancer 
5. Screening 
6. Culture or Cultural Factors 
7. Ethnicity 
8. Knowledge, Attitudes and 
Values 
9. Qualitative Studies 
10. Focus Groups 
Articles that are: 
1. Non-English 
2. Related to study 
participation 
3. Related to cancers other 
than prostate cancer 
4. Related to treatment 
decisions 
5. Case Studies/Series, 
Editorials, Reviews 
6. Related to Genetic Testing 
7. No comparison group 
2. Ashford et al (2001) No Non-Qualitative study 
3. .et al. (2004) No related 
4 
9. Clarke-Tasker VA et al (2005) No Non-Qualitative study 
10. Edwards et al. (2002) No Non-Qualitative study 
11. Fearing et al. (2000) No Non-Qualitative study 
23. Steele et al (2000) No Non-qualitative 
24. Taylor et al (2006) No Non-qualitative 
27. Weinrich et al (2003) No Non-qualitative study 
28. Wilkinson et al. (2003) No Non-qualitative, +knowledge 
Other Excluded Articles 
Agho A, and Lewis MA. Correlates of actual and perceived knowledge of prostate cancer among African 
Americans. Cancer Nurs. 2001 Jun;24(3):165-71. 
Ashford AR, Albert SM eta f. Prostate carcinoma knowledge, attitudes, and screening behavior among African 
American men in Central Harlem, New York City. Cancer. 2001 Jan 1;91(1):164-72. 
Bailey DE, Mishel MH eta f. Uncertainty intervention for watchful waiting in prostate cancer. Cancer Nursing. 
2004 Sep-Oct;27(5):339-46. 
Blanchard K, Proverbs-Singh eta f. Knowledge, attitudes and beliefs of women about the importance of prostate 
cancer screening. J Natl Med Assoc. 2005 Oct;97(10):1378-85. 
Brown M, Davis JL eta f. Assessment of preventive health knowledge and behaviors of African-American and 
Afro-Caribbean women in urban settings. J Natl Med Assoc. 2006 Oct;98(10):1644-51. 
Chan EC, Vernon SW eta f. Informed consent for cancer screening with prostate-specific antigen: how well are 
men getting the message? Am J Public Health. 2003 May;93(5):779-85. 
Clarke-Takser VA, Dutta AP. African-American men and their reflections and thoughts on prostate cancer. J Natl 
Black Nurses Assoc. 2005 Jul;16(1):1-7. 
Edwards QT, Johnson CG, eta f. Differentiation of the health behavior patterns related to prostate cancer 
screening among African-American men in military settings. Military Med. 2002 May;167(5):374-8. 
Fearing A, Bell D eta f. Prostate screening health beliefs and practices of African American men. 
ABNF J. 2000 Nov-Dec;11(6):141-4 
Hart A, Bowen DJ. The feasibility of partnering with African-American barbershops to provide prostate cancer 
education. Ethn Dis. 2004 Spring;14(2):269-73. 
Lambert S, Fearing A eta f. A comparative study of prostate screening health beliefs and practices between 
African American and Caucasian men. ABNF J. 2002 May-Jun;13(3):61-3. 
Nivens AS, Herman J eta f. Cues to participation in prostate cancer screening: a theory for practice. Oncol Nurs 
Forum. 2001 Oct;28(9):1449-56. 
Ross LE, Uhler RJ eta f. Awareness and use of the prostate-specific antigen test among African-American men. J 
Natl Med Assoc. 2005 Jul;97(7):963-71. 
Steele CB, Miller DS. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. 
Am J Public Health. 2000 Oct;90(10):1595-600. 
Taylor,KL Davis JL eta f. Educating African American men about the prostate cancer screening dilemma: a 
randomized intervention. Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2179-88. 
Trauth JM, Jernigan JC eta f. Factors affecting older African American women's decisions to join the PLCO Cancer 
Screening Trial. J Clin Oncol. 2005 Dec 1;23(34):8730-8. 
Weinrich SP, Weinrich MC. Self-reported reasons men decide not to participate in free prostate cancer 
screening. Oncol Nurs Forum. 2003 Jan-Feb;30(1):E12-6. 
Figure 3. Psycholnfo Search Strategy 
Search Date: March 14, 2007 
Search terms: (African American* OR Black) AND Screen* AND Prostate Cancer AND (Cultur* or Values) 
published since 2000. 
Results: 9 articles 
9 Articles Identified 
------- -------I Non- Qualitative Studies (n=5) I Qualitative Studies (n=4) I 
~ 
Qualitative+ Knowledge, 
Qualitative Studies Qualitative studies, No Awareness, NOT Prostate 
+ Met all inclusion/Exclusion 
comparison group (n=2) Cancer, NOT Men (n= 1) Criteria (n=1) 
TOTAL ARTICLES (n=l) 
1. Abernethy et al. (2005) No Review article 
2. Belin et al. (2006) No Not prostate Cancer, Not Men 
3. Blocker et al. (2006) No Qualitative study, no comparison group 
4. Chan EC, Haynes M, et al (2003) Yes Qualitative Study, + comparison group 
5. Kim et al (2006) No Dissertation 
6. Kudadjie-Gyamfi et al (2006) No Quantitative, Coping styles & culture 
7. Lewis (2003) No Comment/Reply 
8. Odedina et al {2004) No Qualitative Study, no comparison group 
9. Sellars et al (2003) No Review article 
Figure 4. MEDLINE and Psych Info Searches 
MEDLINE 
Total Articles 
(n=3) 
Psych Info 
Total Articles 
(n=l) 
Total Articles for final 
SER(n-4) 
Figure 5: Research Design Methods 
Healthy Men 
ages 40-80 
recruited from community centers, clinics, churches, gyms, meal 
sites, construction sites and other grass roots organizations 
through flyers, media and word of mouth. 
Ineligible men Excluded 
~ (n= x) Telephone Eligibility Interview 
(n=x) ~ Men who declined study participation (n= x) 
1- Randomization 
J I 
Culturally Tailored Education Group 
Neutral Education group No Education group (n=x) (n=x) ln=x) 
I 
African American Latino Men White Men African American African American 
Men Men Men 
Latino Men Latino Men 
White Men White Men 
(n= x) (n= x) (n= x) (n=x) (n=x) 
~ 
Computer based Computer based Computer based Computer based Computer based Surveys (pre. Surveys (pre, Surveys (pre, post- Surveys (pre. post- surveys (pre, post-post- intervention. post- intervention, intervention, 6 mo intervention, 6 mo flu intervention, 6 mo flu 6 mo flu mail-in)+ 6 mo flu mail-in) flu mail-in)+ (1) mail-in)+ (1) Non- mail-in)+ (1) No (1) African + (1) Latino European American culturally tailored Prostate Cancer American tailored culturally tailored culturally tailored, (neutral) Educational Educational video + educational video educational video educational video + video + (2) Neutral (2) No Values + (2) culturally + (2) culturally (2) culturally tailored Values Clarification Clarification exercise tailored VC tailored VC VC exercise + exercise + (3) post- + (3) post-trial focus exercises + (3) exercises+ (3) post-trial focus trial focus group group session post-trial focus (3) post-trial focus group session session group session group session 
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Randomization 
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Culturally Tailored Education Group Neutral Education group No Education group (n=x) (n=x) ln=x\ 
African American Latino Men White Men African American African American 
Men Men Men 
Latino Men Latino Men 
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Abstract 
Objectives: The purpose of this paper is to determine the culturally based values, attitudes and 
beliefs that influence African American men in their decisions to undergo prostate cancer 
screening. These beliefs, values and concerns will then be used to create a research design to 
assess the effectiveness of a culturally tailored intervention (educational video and values 
clarification exercise) in helping men make decisions that are consistent with their values and 
beliefs, by increasing knowledge, identifying values, attitudes and beliefs, reducing decisional 
conflict and identifying preferred role in decision making. 
Methods: A systematic evidence review was conducted to determine the culturally specific 
values, attitudes and beliefs of African American, Latino and White men. The thematic results of 
the systematic evidence review were used to craft a research design including surveys, 
educational videos, and values clarification exercises (social matching and ranking and rating). 
Results: Important recurring themes were identified in the systematic evidence review. These 
themes included lack of knowledge, machismo, fear, patient doctor relationship, family and faith. 
All men reported poor patient doctor relationship, negative perceptions of prostate cancer, lack 
of knowledge and the importance of family. African American and Latino men were more likely 
to fear prostate cancer screening methods (ORE). All groups gave specific and unique 
suggestions for the content, design and themes they would prefer in educational materials. 
In the research design, the primary outcomes will be knowledge, decisional conflict and 
values, attitudes and beliefs and preferred role in decision making. We do not expect a 
statistically significant difference between groups in intent to screen and knowledge. However, a 
statistically significant difference in decisional conflict is hypothesized between the culturally 
tailored, neutral and no education groups. Values, attitudes and beliefs will be assessed through 
values clarification exercises and survey questions. We expect that importance of support 
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